Apolipoprotein M
Kun Ren1, Zhen-Li Tang1, Yue Jiang1
1Institute of Cardiovascular Disease, Key Lab for Arteriosclerology of Hunan Province, University of South China, Hengyang City 421001 Hunan Province, China.
Abstract:
Apolipoprotein M (ApoM) is a novel apolipoprotein that was discovered in 1999 and is bound primarily to high-density lipoproteins (HDLs) in the plasma. Multiple factors may influence its expression at both the post-transcriptional and the transcriptional levels both in vivo and ex vivo as follows: hepatocyte nuclear factor-1α, 4α (HNF-1α, 4α), liver receptor homolog-1 (LRH-1), forkhead box A2 (Foxa2) and platelet activating factor (PAF) upregulate its expression; liver X receptor (LXR), retinoid X receptor (RXR), farnesoid X receptor (FXR), small heterodimer partner (SHP) and the majority of cytokines downregulate its expression. However, mechanisms underlying these processes remain unknown. Structurally, there exists a characterized hydrophobic binding pocket within the apoM protein, which enables it to bind functional lipids such as Sphingosine-1-Phosphate (S1P). Functionally, it facilitates the formation of preβ-HDL and enhances an avalanche of atheroprotective effects exerted by HDL. Moreover, in patients with diabetes, the levels of plasma apoM may decrease, whereas the augmentation of apoM decreases plasma glucose levels and magnifies the secretion of insulin. This article offers a panorama of the progress made in the research regarding the characteristics of apoM, particularly the regulation of its expression and its functions.
Insights
Apolipoprotein M (ApoM) is a protein influencing HDL function and lipid binding. Research explores its expression regulation and potential therapeutic roles in diabetes by modulating glucose and insulin levels.
Area of Science:
- Biochemistry
- Molecular Biology
- Endocrinology
Background:
- Apolipoprotein M (ApoM) is a plasma protein primarily associated with high-density lipoproteins (HDLs).
- Its expression is regulated by various transcription factors and signaling molecules.
- ApoM binds functional lipids like Sphingosine-1-Phosphate (S1P).
Purpose of the Study:
- To review the characteristics of Apolipoprotein M (ApoM).
- To elucidate the regulatory mechanisms of ApoM expression.
- To summarize the functional roles of ApoM, including its impact on HDL and glucose metabolism.
Main Methods:
- Literature review of studies on Apolipoprotein M (ApoM).
- Analysis of factors influencing ApoM gene expression (transcriptional and post-transcriptional).
- Examination of ApoM's structural and functional properties, including lipid binding and effects on HDL.
Main Results:
- Multiple factors like HNF-1α, 4α, LRH-1, and Foxa2 upregulate ApoM expression.
- Receptors such as LXR, RXR, FXR, and SHP, along with cytokines, downregulate ApoM expression.
- ApoM facilitates preβ-HDL formation, exerts atheroprotective effects, and may improve glucose control and insulin secretion in diabetes.
Conclusions:
- Apolipoprotein M (ApoM) plays a significant role in HDL functionality and lipid metabolism.
- Understanding ApoM expression regulation is crucial for its therapeutic potential.
- ApoM augmentation shows promise for managing diabetes by improving glycemic control and insulin secretion.
More Related Videos
Related Concept Videos
Leaky Scanning
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
RNA Editing
Immunoprecipitation
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
The ADP/ATP Carrier Protein


